AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 54 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.54 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,885 | -93.9% | 16,900 | -96.7% | 0.00% | -100.0% |
| Q4 2022 | $457,004 | -3.8% | 506,600 | +24.6% | 0.00% | 0.0% |
| Q3 2022 | $475,000 | +813.5% | 406,700 | +401.5% | 0.00% | +300.0% |
| Q2 2022 | $52,000 | -80.1% | 81,100 | -18.9% | 0.00% | -50.0% |
| Q1 2022 | $261,000 | -36.5% | 100,000 | -5.4% | 0.00% | -50.0% |
| Q4 2021 | $411,000 | +109.7% | 105,700 | +844.4% | 0.00% | -55.6% |
| Q3 2018 | $196,000 | – | 11,192 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $11,479,000 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 695,258 | $813,000 | 2.80% |
| Latash Investments, LLC | 243,134 | $284,000 | 0.23% |
| Bracebridge Capital, LLC | 428,571 | $501,000 | 0.09% |
| Running Point Capital Advisors, LLC | 10,000 | $12,000 | 0.01% |
| D.B. Root & Company, LLC | 12,500 | $14,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 406,700 | $475,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 142,956 | $167,000 | 0.00% |
| IFP Advisors, Inc | 6,500 | $104,000 | 0.00% |
| Financial Advocates Investment Management | 27,000 | $32,000 | 0.00% |